Zhi Jian Chen
Direktor/Vorstandsmitglied bei Shanghai Haihe Biopharma Co., Ltd.
Aktive Positionen von Zhi Jian Chen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Shanghai Haihe Biopharma Co., Ltd.
 Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
Huatai Futures Co., Ltd.
 Huatai Futures Co., Ltd. Investment ManagersFinance Part of Huatai Securities Co., Ltd., Huatai Futures Co., Ltd. provides investment brokerage and asset management services. The company is based in Guangzhou, China. The Chinese company was founded in 1994. The CEO is Chang Tao Zhao. | Direktor/Vorstandsmitglied | 28.12.2010 | - |
Karriereverlauf von Zhi Jian Chen
Ehemalige bekannte Positionen von Zhi Jian Chen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DELUXE FAMILY CO., LTD. | Direktor/Vorstandsmitglied | 23.08.2010 | 31.05.2012 |
| General Counsel | 23.08.2010 | 31.05.2012 | |
| Shanghai Nanjiang Group Co. Ltd. /Old/ | Direktor/Vorstandsmitglied | 06.01.2012 | 06.01.2012 |
Statistik
International
| China | 5 |
Operativ
| Director/Board Member | 4 |
| General Counsel | 1 |
Sektoral
| Finance | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DELUXE FAMILY CO., LTD. | Finance |
| Private Unternehmen | 3 |
|---|---|
| Shanghai Nanjiang Group Co. Ltd. /Old/ | Finance |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |
Huatai Futures Co., Ltd.
Huatai Futures Co., Ltd. Investment ManagersFinance Part of Huatai Securities Co., Ltd., Huatai Futures Co., Ltd. provides investment brokerage and asset management services. The company is based in Guangzhou, China. The Chinese company was founded in 1994. The CEO is Chang Tao Zhao. | Finance |
- Börse
- Insiders
- Zhi Jian Chen
- Erfahrung
